Risk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting?

BACKGROUND: The risk of pre-term birth (PTB) associated with the use of protease inhibitors (PIs) during pregnancy remains a subject of debate. Recent data suggest that ritonavir boosting of PIs may play a specific role in the initiation of PTB, through an effect on the maternal–fetal adrenal axis....

Descripción completa

Detalles Bibliográficos
Autores principales: Kakkar, Fatima, Boucoiran, Isabelle, Lamarre, Valerie, Ducruet, Thierry, Amre, Devendra, Soudeyns, Hugo, Lapointe, Normand, Boucher, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458515/
https://www.ncbi.nlm.nih.gov/pubmed/26051165
http://dx.doi.org/10.7448/IAS.18.1.19933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458515/
https://www.ncbi.nlm.nih.gov/pubmed/26051165
http://dx.doi.org/10.7448/IAS.18.1.19933

Ejemplares similares